Iterum Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITRM and other ETFs, options, and stocks.About ITRM
Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N.
CEOCorey N. Fishman
CEOCorey N. Fishman
Employees9
Employees9
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2015
Founded2015
Employees9
Employees9
ITRM Key Statistics
Market cap18.55M
Market cap18.55M
Price-Earnings ratio-0.47
Price-Earnings ratio-0.47
Dividend yield—
Dividend yield—
Average volume396.80K
Average volume396.80K
High today$0.36
High today$0.36
Low today$0.3191
Low today$0.3191
Open price$0.32
Open price$0.32
Volume401.11K
Volume401.11K
52 Week high$1.75
52 Week high$1.75
52 Week low$0.26
52 Week low$0.26
Stock Snapshot
Iterum Therapeutics(ITRM) stock is priced at $0.35, giving the company a market capitalization of 18.55M. It carries a P/E multiple of -0.47.
On 2026-01-23, Iterum Therapeutics(ITRM) stock moved within a range of $0.32 to $0.36. With shares now at $0.35, the stock is trading +10.0% above its intraday low and -2.5% below the session's peak.
Trading activity shows a volume of 401.11K, compared to an average daily volume of 396.8K.
The stock's 52-week range extends from a low of $0.26 to a high of $1.75.
The stock's 52-week range extends from a low of $0.26 to a high of $1.75.
People also own
Based on the portfolios of people who own ITRM. This list is generated using Robinhood data, and it’s not a recommendation.